Aurélia Galus

Title: Aurélia Galus: Innovator in Pharmaceutical Formulations

Introduction

Aurélia Galus is a notable inventor based in Weyersheim, France. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on the oral delivery of poorly permeable molecules. With a total of 3 patents to his name, Galus is recognized for his innovative approaches to enhancing drug delivery systems.

Latest Patents

Galus's latest patents include a formulation for oral delivery of proteins, peptides, and small molecules with poor permeability. This pharmaceutical formulation is designed for the oral delivery of synthetic or natural poorly permeable molecules or salts/solvates that possess therapeutic activity. The formulation comprises a poorly permeable molecule in an amount of 0.01-10 wt. % of the total weight, a lipophilic phase consisting of triglycerides of fatty acids in an amount of 50-80 wt. %, and at least one lipophilic surfactant made up of partial esters of polyol and fatty acids in an amount of about 10-50 wt. % of the total weight.

Career Highlights

Aurélia Galus is currently associated with R.P. Scherer Technologies, Inc., where he continues to develop innovative pharmaceutical solutions. His work has been instrumental in advancing the field of drug delivery, particularly for challenging compounds that exhibit poor permeability.

Collaborations

Galus has collaborated with notable colleagues such as Vincent Plassat and Benoit Hilbold, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.

Conclusion

Aurélia Galus stands out as a key figure in the realm of pharmaceutical innovations, particularly in the development of formulations that enhance the oral delivery of poorly permeable molecules. His contributions are paving the way for more effective therapeutic solutions in the pharmaceutical industry.